跳至主要内容
临床试验/NCT01932073
NCT01932073已完成不适用

Low-Level Laser Therapy for the Management of Radiation Dermatitis: A Pilot Study in Breast Cancer Patients

Hasselt University2 个研究点 分布在 1 个国家目标入组 79 人开始时间: 2013年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
79
试验地点
2
主要终点
Radiation Dermatitis Grade

研究概览

简要总结

Low Level Laser Therapy (LLLT) is a form of phototherapy which involves the application of light to injuries and lesions to promote tissue regeneration. It is a noninvasive treatment modality based on the photochemical effect of light on tissues, which modulates various metabolic processes.

LLLT has been used for a wide range of conditions, in particular in dermatology, to promote wound healing, reduce inflammation and oedema, and relieve pain. In this study, we intend to assess the efficacy of LLLT to manage radiotherapy-induced skin reactions (or radiation dermatitis), a very common and distressing side effect of cancer treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Diagnosis of noninvasive (Stage 0) or invasive (Stages 1, 2 or 3A) breast adenocarcinoma
  • Treatment with primary breast-sparing surgery (lumpectomy) and/ or neoadjuvant (preoperative) or adjuvant (postoperative) chemotherapy or hormonal treatment
  • Scheduled for postoperative radiotherapy with standard technique (isocentric) and fractionation regime (i.e., 25 daily fractions to the whole breast followed by a boost of 8 fractions to the tumor bed, 2 Gy per fraction, five times per week)
  • Provide signed informed consent

排除标准

  • Previous irradiation to the same breast
  • Metastatic disease
  • Mastectomy surgery
  • Concurrent chemo-radiotherapy
  • Required use of bolus material to deliver radiation therapy (i.e., material placed on the to-be-irradiated zone to modulate the delivered dose in order to ensure an optimal distribution of the radiation dose)

结局指标

主要结局

Radiation Dermatitis Grade

时间窗: 3 months (during radiation therapy and one month after)

objective scoring of the severity of radiation dermatitis using the grading system of the Radiation Therapy Oncology Group/ European Organization for Research and Treatment of Cancer (RTOG/ EORTC).

Pain

时间窗: 3 months (during radiation therapy and one month after)

evaluation of pain using a visual analogue scale

Radiation Dermatitis Assessment

时间窗: 3 months (during radiation therapy and one month after)

Radiation dermatitis assessment scale (Radiation-Induced Skin Reaction Assessment Scale, RISRAS)

次要结局

  • Impact of Radiation Dermatitis(3 months (during radiation therapy and one month after))
  • Satisfaction with therapy(3 months (during radiation therapy and one month after))
  • Quality of Life(3 months (during radiation therapy and one month after))

研究者

发起方
Hasselt University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. dr. Jeroen Mebis

MD, PhD

Hasselt University

研究点 (2)

Loading locations...

相似试验